Please assess the completion status of the following clinical trial:

Trial Title: Safety and Efficacy Study of GS-5806 in Healthy Volunteers Infected With Respiratory Syncytial Virus (RSV)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Healthy male or female~* Between 18 to 45 years old~* Body Mass Index of 18 to 33 kg/m2~Exclusion Criteria:~* Acute or chronic medical illness~* Positive for Human Immunodeficiency Virus, Hepatitis B or C~* Nose or nasopharynx abnormalities~* Abnormal lung function

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 45 Years
- Healthy Volunteers: t

Study Arms:
- GS-5806 (Type: EXPERIMENTAL): GS-5806, powder for oral solution
- Sugar powder for oral solution in juice (Type: PLACEBO_COMPARATOR): Sugar powder for oral solution

Based on this trial design, predict the completion outcome and termination type (if applicable).